Kara Cannon's most recent trade in Enzo Biochem, Inc. was a trade of 70,885 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on July 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. | Kara Cannon | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. | 24 Jul 2024 | 70,885 | 380,412 (0%) | 0% | 1.2 | 82,935 | Common Stock |
| Enzo Biochem, Inc. | Kara Cannon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 200,000 | 200,000 | - | - | Stock Option (to acquire shares of Common Stock) | |
| Enzo Biochem, Inc. | Cannon Kara | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 150,000 | 451,297 (0%) | 0% | 0 | Common Stock | |
| Enzo Biochem, Inc. | Kara Cannon | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 10,640 | 307,120 (0%) | 0% | 0 | Common Stock | |
| Enzo Biochem, Inc. | Cannon Kara | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 21 Feb 2024 | 5,823 | 301,297 (0%) | 0% | 0 | Common Stock | |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 345,080 | 360,180 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. | 31 Aug 2023 | 63,700 | 296,480 (0%) | 0% | 1.5 | 98,098 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2022 | 12,600 | 15,100 (0%) | 0% | - | Common Stock, $0.01 Par Value | |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 200,000 | 200,000 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 15 Jul 2022 | 2,500 | 2,500 (0%) | 0% | 2.4 | 6,050 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | Kara Cannon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 87,500 | 87,500 | - | - | Stock Option (to acquire Common Stock) |